YAMADA Consulting Group  CO.,LTD. Logo

YAMADA Consulting Group CO.,LTD.

Japanese consulting firm offering global M&A, strategy, and financial advisory services.

4792 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区丸の内1−8−1丸の内トラストタワーN館
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

YAMADA Consulting Group is one of Japan's largest independent consulting firms, providing a comprehensive range of management and financial advisory services. The company specializes in business consulting for small and medium-sized enterprises but also serves multinational corporations and government agencies. Core services include strategy development based on primary information, investment research, and M&A transaction support. With a direct presence in Asia, the Middle East, and the USA, and through strategic partnerships such as Clairfield International, YAMADA offers seamless cross-border M&A advisory and global consulting solutions. The firm's subsidiary, Yamada Consulting & Spire, acts as a regional headquarters to capitalize on opportunities in the Asian market.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for YAMADA Consulting Group CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-24 10:02
Regulatory News Service
臨時報告書
Japanese 27.5 KB
2025-06-20 09:53
Regulatory News Service
内部統制報告書-第36期(2024/04/01-2025/03/31)
Japanese 23.2 KB
2025-06-20 09:53
Regulatory News Service
確認書
Japanese 8.6 KB
2025-06-20 09:52
Annual Report
有価証券報告書-第36期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-05-27 09:24
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-01-10 03:36
Regulatory News Service
臨時報告書
Japanese 20.0 KB
2024-11-13 08:26
Interim Report
半期報告書-第36期(2024/04/01-2025/03/31)
Japanese 214.7 KB
2024-11-13 08:26
Regulatory News Service
確認書
Japanese 8.5 KB
2024-06-28 07:21
Regulatory News Service
臨時報告書
Japanese 23.7 KB
2024-06-28 06:18
Regulatory News Service
内部統制報告書-第35期(2023/04/01-2024/03/31)
Japanese 22.8 KB
2024-06-28 06:17
Regulatory News Service
確認書
Japanese 8.6 KB
2024-06-28 06:15
Annual Report
有価証券報告書-第35期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-13 06:38
Regulatory News Service
確認書
Japanese 8.5 KB
2024-02-13 06:37
Quarterly Report
四半期報告書-第35期第3四半期(2023/10/01-2023/12/31)
Japanese 197.9 KB
2023-11-13 08:23
Regulatory News Service
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all YAMADA Consulting Group CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for YAMADA Consulting Group CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766

Talk to a Data Expert

Have a question? We'll get back to you promptly.